Netrin-1 and Cyclophilin A : biomarkers of inflammation and kidney injury in Alport syndrome: a pilot study

Background: Netrin-1 and Cyclophilin A (CypA) participate in the pathological processes of inflammation, oxidative stress and apoptosis. Our objective was to determine the level of serum Netrin-1 & Cyclophilin A (CypA) in Alport syndrome. Materials and Methods: The study included 10 Alport syndr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:New Zealand journal of medical laboratory science 2022-11, Vol.76 (3), p.50-52
Hauptverfasser: Zaki, Moushira, Fadel, Fatina I, Toukhy, Safinaz Ebrahim El, Youness, Eman R, Selim, Abeer, Sonbaty, Mohamed El, Bassyouni, Hala T. El
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 52
container_issue 3
container_start_page 50
container_title New Zealand journal of medical laboratory science
container_volume 76
creator Zaki, Moushira
Fadel, Fatina I
Toukhy, Safinaz Ebrahim El
Youness, Eman R
Selim, Abeer
Sonbaty, Mohamed El
Bassyouni, Hala T. El
description Background: Netrin-1 and Cyclophilin A (CypA) participate in the pathological processes of inflammation, oxidative stress and apoptosis. Our objective was to determine the level of serum Netrin-1 & Cyclophilin A (CypA) in Alport syndrome. Materials and Methods: The study included 10 Alport syndrome patients, their age ranged from 5-13 years (8.50[+ or - ]2.87) (mean age [+ or -]SD), they were 7 females and 3 males (ratio of 1:0.43) and 10 age and sex matched healthy children. Serum Netrin-1 and Cyclophilin A (CypA) were measured using ELISA kits. Results: All patients presented with haematuria, while 3 cases had mild proteinuria. The renal pathology revealed features like thin basement membrane disease. Sensorineural hearing loss was present in 8 patients and no patients had retinitis pigmentosa. The serum levels of Netrin-1 were 160.47ng/mL [+ or -] 12.833 for controls and 141.91ng/mL [+ or -]16.953 for patients (p < 0.01), for CypA was 7.55ng/mL [+ or -]0.74 in patients compared to 6.27ng/mL [+ or -]0.37 in controls (p
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2736852621</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A732235299</galeid><sourcerecordid>A732235299</sourcerecordid><originalsourceid>FETCH-LOGICAL-g951-1783548ca03de638c713007a1ac0dd62e03e6b848bdcce8c0b66dfb278cefc2e3</originalsourceid><addsrcrecordid>eNptj8tqwzAQRb1ooenjHwRdu-gRS3J2JvQFod1kb2RpnCqRJVeyF_77qg9oF2UWFw5nZrhnxYoQQUpM6uqiuEzpiPGas6peFacXmKL1JUHKG7RdtAvjm3XWowZtUGfDoOIJYkKhR9b3Tg2DmmzwX_rJGg9L5sc5fgZq3BjihNLiTQwDbJBCo3Uhk2k2y3Vx3iuX4OYnr4r9w_1--1TuXh-ft82uPNQVKYmQrFpLrTAzwJnUgjCMhSJKY2M4BcyAd3ItO6M1SI07zk3fUSE19JoCuypuv8-OMbzPkKb2GObo88eWCsZlRTklv9ZBOWhztTBFpQebdNsIRimraF1n6-4fK4-BwergobeZ_1n4AE5xbwY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2736852621</pqid></control><display><type>article</type><title>Netrin-1 and Cyclophilin A : biomarkers of inflammation and kidney injury in Alport syndrome: a pilot study</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Zaki, Moushira ; Fadel, Fatina I ; Toukhy, Safinaz Ebrahim El ; Youness, Eman R ; Selim, Abeer ; Sonbaty, Mohamed El ; Bassyouni, Hala T. El</creator><creatorcontrib>Zaki, Moushira ; Fadel, Fatina I ; Toukhy, Safinaz Ebrahim El ; Youness, Eman R ; Selim, Abeer ; Sonbaty, Mohamed El ; Bassyouni, Hala T. El</creatorcontrib><description>Background: Netrin-1 and Cyclophilin A (CypA) participate in the pathological processes of inflammation, oxidative stress and apoptosis. Our objective was to determine the level of serum Netrin-1 &amp; Cyclophilin A (CypA) in Alport syndrome. Materials and Methods: The study included 10 Alport syndrome patients, their age ranged from 5-13 years (8.50[+ or - ]2.87) (mean age [+ or -]SD), they were 7 females and 3 males (ratio of 1:0.43) and 10 age and sex matched healthy children. Serum Netrin-1 and Cyclophilin A (CypA) were measured using ELISA kits. Results: All patients presented with haematuria, while 3 cases had mild proteinuria. The renal pathology revealed features like thin basement membrane disease. Sensorineural hearing loss was present in 8 patients and no patients had retinitis pigmentosa. The serum levels of Netrin-1 were 160.47ng/mL [+ or -] 12.833 for controls and 141.91ng/mL [+ or -]16.953 for patients (p &lt; 0.01), for CypA was 7.55ng/mL [+ or -]0.74 in patients compared to 6.27ng/mL [+ or -]0.37 in controls (p&lt;0.001). Conclusion: To the best of our knowledge, this is the first research to investigate the levels of Netrin-1 and Cyclophilin A in Alport syndrome patients. Keywords: Alport syndrome, Cyclophilin A (CypA), Netrin-1, inflammation. N Z J Med Lab Sci 2022; 76(3): 136-138</description><identifier>ISSN: 1171-0195</identifier><language>eng</language><publisher>Auckland: New Zealand Institute of Medical Laboratory Science</publisher><subject>Age ; Apoptosis ; Biomarkers ; Hearing loss ; Hematuria ; Inflammation ; Kidney diseases ; Medical research ; Medicine, Experimental ; Mutation ; Oxidative stress ; Pathology ; Pediatrics ; Research centers</subject><ispartof>New Zealand journal of medical laboratory science, 2022-11, Vol.76 (3), p.50-52</ispartof><rights>COPYRIGHT 2022 New Zealand Institute of Medical Laboratory Science</rights><rights>Copyright New Zealand Institute of Medical Laboratory Science Nov 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Zaki, Moushira</creatorcontrib><creatorcontrib>Fadel, Fatina I</creatorcontrib><creatorcontrib>Toukhy, Safinaz Ebrahim El</creatorcontrib><creatorcontrib>Youness, Eman R</creatorcontrib><creatorcontrib>Selim, Abeer</creatorcontrib><creatorcontrib>Sonbaty, Mohamed El</creatorcontrib><creatorcontrib>Bassyouni, Hala T. El</creatorcontrib><title>Netrin-1 and Cyclophilin A : biomarkers of inflammation and kidney injury in Alport syndrome: a pilot study</title><title>New Zealand journal of medical laboratory science</title><description>Background: Netrin-1 and Cyclophilin A (CypA) participate in the pathological processes of inflammation, oxidative stress and apoptosis. Our objective was to determine the level of serum Netrin-1 &amp; Cyclophilin A (CypA) in Alport syndrome. Materials and Methods: The study included 10 Alport syndrome patients, their age ranged from 5-13 years (8.50[+ or - ]2.87) (mean age [+ or -]SD), they were 7 females and 3 males (ratio of 1:0.43) and 10 age and sex matched healthy children. Serum Netrin-1 and Cyclophilin A (CypA) were measured using ELISA kits. Results: All patients presented with haematuria, while 3 cases had mild proteinuria. The renal pathology revealed features like thin basement membrane disease. Sensorineural hearing loss was present in 8 patients and no patients had retinitis pigmentosa. The serum levels of Netrin-1 were 160.47ng/mL [+ or -] 12.833 for controls and 141.91ng/mL [+ or -]16.953 for patients (p &lt; 0.01), for CypA was 7.55ng/mL [+ or -]0.74 in patients compared to 6.27ng/mL [+ or -]0.37 in controls (p&lt;0.001). Conclusion: To the best of our knowledge, this is the first research to investigate the levels of Netrin-1 and Cyclophilin A in Alport syndrome patients. Keywords: Alport syndrome, Cyclophilin A (CypA), Netrin-1, inflammation. N Z J Med Lab Sci 2022; 76(3): 136-138</description><subject>Age</subject><subject>Apoptosis</subject><subject>Biomarkers</subject><subject>Hearing loss</subject><subject>Hematuria</subject><subject>Inflammation</subject><subject>Kidney diseases</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Mutation</subject><subject>Oxidative stress</subject><subject>Pathology</subject><subject>Pediatrics</subject><subject>Research centers</subject><issn>1171-0195</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptj8tqwzAQRb1ooenjHwRdu-gRS3J2JvQFod1kb2RpnCqRJVeyF_77qg9oF2UWFw5nZrhnxYoQQUpM6uqiuEzpiPGas6peFacXmKL1JUHKG7RdtAvjm3XWowZtUGfDoOIJYkKhR9b3Tg2DmmzwX_rJGg9L5sc5fgZq3BjihNLiTQwDbJBCo3Uhk2k2y3Vx3iuX4OYnr4r9w_1--1TuXh-ft82uPNQVKYmQrFpLrTAzwJnUgjCMhSJKY2M4BcyAd3ItO6M1SI07zk3fUSE19JoCuypuv8-OMbzPkKb2GObo88eWCsZlRTklv9ZBOWhztTBFpQebdNsIRimraF1n6-4fK4-BwergobeZ_1n4AE5xbwY</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>Zaki, Moushira</creator><creator>Fadel, Fatina I</creator><creator>Toukhy, Safinaz Ebrahim El</creator><creator>Youness, Eman R</creator><creator>Selim, Abeer</creator><creator>Sonbaty, Mohamed El</creator><creator>Bassyouni, Hala T. El</creator><general>New Zealand Institute of Medical Laboratory Science</general><scope>3V.</scope><scope>7RV</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AYAGU</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>KB0</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20221101</creationdate><title>Netrin-1 and Cyclophilin A : biomarkers of inflammation and kidney injury in Alport syndrome: a pilot study</title><author>Zaki, Moushira ; Fadel, Fatina I ; Toukhy, Safinaz Ebrahim El ; Youness, Eman R ; Selim, Abeer ; Sonbaty, Mohamed El ; Bassyouni, Hala T. El</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g951-1783548ca03de638c713007a1ac0dd62e03e6b848bdcce8c0b66dfb278cefc2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age</topic><topic>Apoptosis</topic><topic>Biomarkers</topic><topic>Hearing loss</topic><topic>Hematuria</topic><topic>Inflammation</topic><topic>Kidney diseases</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Mutation</topic><topic>Oxidative stress</topic><topic>Pathology</topic><topic>Pediatrics</topic><topic>Research centers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zaki, Moushira</creatorcontrib><creatorcontrib>Fadel, Fatina I</creatorcontrib><creatorcontrib>Toukhy, Safinaz Ebrahim El</creatorcontrib><creatorcontrib>Youness, Eman R</creatorcontrib><creatorcontrib>Selim, Abeer</creatorcontrib><creatorcontrib>Sonbaty, Mohamed El</creatorcontrib><creatorcontrib>Bassyouni, Hala T. El</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Australia &amp; New Zealand Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>New Zealand journal of medical laboratory science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zaki, Moushira</au><au>Fadel, Fatina I</au><au>Toukhy, Safinaz Ebrahim El</au><au>Youness, Eman R</au><au>Selim, Abeer</au><au>Sonbaty, Mohamed El</au><au>Bassyouni, Hala T. El</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Netrin-1 and Cyclophilin A : biomarkers of inflammation and kidney injury in Alport syndrome: a pilot study</atitle><jtitle>New Zealand journal of medical laboratory science</jtitle><date>2022-11-01</date><risdate>2022</risdate><volume>76</volume><issue>3</issue><spage>50</spage><epage>52</epage><pages>50-52</pages><issn>1171-0195</issn><abstract>Background: Netrin-1 and Cyclophilin A (CypA) participate in the pathological processes of inflammation, oxidative stress and apoptosis. Our objective was to determine the level of serum Netrin-1 &amp; Cyclophilin A (CypA) in Alport syndrome. Materials and Methods: The study included 10 Alport syndrome patients, their age ranged from 5-13 years (8.50[+ or - ]2.87) (mean age [+ or -]SD), they were 7 females and 3 males (ratio of 1:0.43) and 10 age and sex matched healthy children. Serum Netrin-1 and Cyclophilin A (CypA) were measured using ELISA kits. Results: All patients presented with haematuria, while 3 cases had mild proteinuria. The renal pathology revealed features like thin basement membrane disease. Sensorineural hearing loss was present in 8 patients and no patients had retinitis pigmentosa. The serum levels of Netrin-1 were 160.47ng/mL [+ or -] 12.833 for controls and 141.91ng/mL [+ or -]16.953 for patients (p &lt; 0.01), for CypA was 7.55ng/mL [+ or -]0.74 in patients compared to 6.27ng/mL [+ or -]0.37 in controls (p&lt;0.001). Conclusion: To the best of our knowledge, this is the first research to investigate the levels of Netrin-1 and Cyclophilin A in Alport syndrome patients. Keywords: Alport syndrome, Cyclophilin A (CypA), Netrin-1, inflammation. N Z J Med Lab Sci 2022; 76(3): 136-138</abstract><cop>Auckland</cop><pub>New Zealand Institute of Medical Laboratory Science</pub><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1171-0195
ispartof New Zealand journal of medical laboratory science, 2022-11, Vol.76 (3), p.50-52
issn 1171-0195
language eng
recordid cdi_proquest_journals_2736852621
source EZB-FREE-00999 freely available EZB journals
subjects Age
Apoptosis
Biomarkers
Hearing loss
Hematuria
Inflammation
Kidney diseases
Medical research
Medicine, Experimental
Mutation
Oxidative stress
Pathology
Pediatrics
Research centers
title Netrin-1 and Cyclophilin A : biomarkers of inflammation and kidney injury in Alport syndrome: a pilot study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A17%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Netrin-1%20and%20Cyclophilin%20A%20:%20biomarkers%20of%20inflammation%20and%20kidney%20injury%20in%20Alport%20syndrome:%20a%20pilot%20study&rft.jtitle=New%20Zealand%20journal%20of%20medical%20laboratory%20science&rft.au=Zaki,%20Moushira&rft.date=2022-11-01&rft.volume=76&rft.issue=3&rft.spage=50&rft.epage=52&rft.pages=50-52&rft.issn=1171-0195&rft_id=info:doi/&rft_dat=%3Cgale_proqu%3EA732235299%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2736852621&rft_id=info:pmid/&rft_galeid=A732235299&rfr_iscdi=true